Market Overview

Global In-vitro Diagnostics Market Outlook to 2023: Advanced Technologies are Spurring Growth -


The "Global
In-vitro Diagnostics Market - Segmented by Technique, Products,
Usability, Application, End Users, and Geography - Growth, Trends, and
Forecast (2018 - 2023)"
report has been added to's

The global in-vitro diagnostics market is expected to register a CAGR of
5.5% during the forecast period of 2018-2023.

Advanced Technologies Spurring the IVD Market

The field of in-vitro diagnostics has witnessed several changes and
additions to its gamut of offerings in the recent past. There has been a
paradigm shift from traditional diagnostics to a new generation
diagnostics that work on gene level. This was possible due to the
inclusion of advanced technology, such as genetic testing, molecular
diagnostics, Polymerase Chain Reaction (PCR), and Next-Generation
Sequencing (NGS).

Fast turnaround, reliability, user-friendliness, and predictability of
predisposed diseases are few significant qualities, which helped these
technologies attain their share in major offerings of diagnosis
providers around the world. Increasing demand from the educated public
for more information about their predisposition for serious diseases,
and how these potential illnesses can be detected at an early stage, is
driving the market for in-vitro diagnostics.

High prevalence of chronic and infectious diseases, increasing use of
point of care (POC) diagnostics, and surging number of private hospitals
and independent testing laboratories are some of the other factors
contributing to the growth of the market.

Other Key Highlights

  • Cumbersome Reimbursement Procedure - A Major Restraint
  • Asia-Pacific to be Lucrative

Notable Developments in the Market

  • Roche acquired Flatiron Health to accelerate industry-wide development
    and delivery of breakthrough medicines for patients with cancer.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Biomerieux
  • Danaher Corporation
  • Roche Diagnostics
  • Becton
  • Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Abbott Laboratories
  • Bayer AG
  • Arkray Inc.
  • Sysmex Corporation
  • Johnson & Johnson
  • Siemens AG

10. Future of the Market

For more information about this report visit

View Comments and Join the Discussion!